Placeholder Banner

GEN Ranks Top Ten U.S. Biopharma Clusters

March 10, 2015
Yesterday, Alex Philippidis at Genetic Engineering and Biotechnology News released their annual ranking of the top 10 U.S. biopharma clusters. To rank the clusers, five criteria are considered: NIH funding, venture capital funding, number of biotech patents awarded, lab space, and jobs.

Landing the number 6 spot is the Greater Philadelphia region, home to this year’s BIO International Convention. From the report:
The birthplace of independence saw a nice year-over-year increase in venture capital financing, leaping almost 30% over 2013 to $211.376 million in 23 deals last year, good enough for fifth on this year’s VC rankings. It’s the strongest sign yet that it has made progress in evolving from a heritage pharma mecca to a more diverse concentration of biopharma businesses and institutions (including 25 medical schools). Philadelphia’s University City Science Center has long been an anchor for regional biopharma; in October it won a $1 million grant from the U.S. Economic Development Administration for a second commercialization program, Phase 1 Ventures. The region is also fifth in jobs (48,874 according to JLL), but seventh in patents (1,195) and lab space (6.62 million square feet), as well as eighth in NIH funding ($87.596 million).

Register today if you’d like to join us in Philly this June. Don’t wait too long – early bird ends April 23.